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Abstract
Progress in the functional studies of human olfactory receptors has been largely hampered by the lack of a reliable
experimental model system. Although transgenic approaches in mice could characterize the function of individual olfactory
receptors, the presence of over 300 functional genes in the human genome becomes a daunting task. Thus, the
characterization of individuals with a genetic susceptibility to altered olfaction coupled with the absence of particular
olfactory receptor genes will allow phenotype/genotype correlations and vindicate the function of specific olfactory
receptors with their cognate ligands. We characterized a 118 kb b-globin deletion and found that its 39 end breakpoint
extends to the neighboring olfactory receptor region downstream of the b-globin gene cluster. This deletion encompasses
six contiguous olfactory receptor genes (OR51V1, OR52Z1, OR51A1P, OR52A1, OR52A5, and OR52A4) all of which are
expressed in the brain. Topology analysis of the encoded proteins from these olfactory receptor genes revealed that
OR52Z1, OR52A1, OR52A5, and OR52A4 are predicted to be functional receptors as they display integral characteristics of G-
proteins coupled receptors. Individuals homozygous for the 118 kb b-globin deletion are afflicted with b-thalassemia due to
a homozygous deletion of the b-globin gene and have no alleles for the above mentioned olfactory receptors genes. This is
the first example of a homozygous deletion of olfactory receptor genes in human. Although altered olfaction remains to be
ascertained in these individuals, such a study can be carried out in b-thalassemia patients from Malaysia, Indonesia and the
Philippines where this mutation is common. Furthermore, OR52A1 contains a c-globin enhancer, which was previously
shown to confer continuous expression of the fetal c-globin genes. Thus, the hypothesis that b-thalassemia individuals, who
are homozygous for the 118 kb deletion, may also have an exacerbation of their anemia due to the deletion of two copies
of the c-globin enhancer element is worthy of consideration.
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Introduction
The b-globin gene locus lies between two olfactory receptor
(OR) gene clusters [1] and is subject to multiple deletions that
cause b-thalassemia, a transfusion-dependent anemia. However,
only three deletions were reported to extend to either olfactory
receptor region. Two deletions break in the upstream olfactory
receptor region, whereby one removes two [2] and the other four
olfactory receptor genes [3]. Because both of these deletions also
take out the embryonic epsilon gene, they have not been
observed in homozygous individuals due to their presumed
embryonic lethality. The third deletion, also occurring in a
heterozygous individual and not reported in a homozygous state,
extends to the downstream olfactory receptor region where it
deletes a single olfactory receptor gene that contains a c-globin
enhancer [4,5].
A large deletion originally reported in Filipinos and known as
the 45 kb deletion [6,7] has a defined upstream breakpoint
between the d and b-globin genes, however its 39 end breakpoint
had not yet been precisely characterized and remains unknown.
In this communication, we report on the accurate characteriza-
tion of the downstream breakpoint of the 45 kb deletion and
uncover that it actually consists of 118 kb and extends to the
downstream olfactory receptor region where it encompasses six
olfactory receptor genes and the previously characterized c-
globin enhancer. As individuals homozygous for the 118 kb
deletion are widespread in Southeast Asia, the possibility arises
they could have altered olfaction due to the homozygous deletion
of the olfactory receptor genes and an exacerbation of their
anemia due to the homozygous deletion of the c-globin
enhancer.
Results
Characterization of the deletion breakpoint
Determination of the DNA sequence from the 376 bp amplicon
spanning the deletion breakpoint (Fig. 1A, 1B) and its subsequent
alignment to the latest DNA sequence of the human genome
(NCBI Bulid 37.1) revealed that 166 bp were homologous to the
intergenic region between the d and b-globin genes, consistent
with a previously reported 59 breakpoint end [7]. However, the
remaining 210 bp, which correspond to the 39 downstream
breakpoint, mapped between the OR genes OR52A4 and
OR52J1P. The two breakpoints were 118,475 bp apart and the
deletion spanned six OR genes: OR51V1, OR52Z1, OR51A1P,
OR52A1, OR52A5, OR52A4 (Fig. 1C).
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Genotyping at the OR gene locus of patients
homozygous for the 118 kb deletion
To confirm the extent of this deletion that we correctly rename
as the 118 kb deletion rather than the 45 kb deletion, we
performed PCR genotyping at each of the six suspected deleted
OR genes in b-thalassemia individuals homozygous for the 118 kb
deletion. As expected, these patients failed to amplify a PCR
amplicon from the b-globin gene and from any of the six OR
genes (Fig. 1D), thus confirming the homozygous deletion of
OR51V1, OR52Z1, OR51A1P, OR52A1, OR52A5, OR52A4.
Topology and expression of the ORs spanned by the
118 kb deletion
Algorithm-based topology predictions of the 6 OR proteins
encompassed by the 118 kb deletion revealed that OR52Z1,
OR52A1, OR52A5, and OR52A4 span each seven transmem-
brane helices (TMHs) that are flanked by extracellular amino and
intracellular carboxy termini. However, OR51V1 and OR51A1P
span six TMHs only and are flanked by two extracellular termini
(Fig. 2A). Thus, OR52Z1, OR52A1, OR52A5 and OR52A4 are
predicted to be functional genes whereas OR51V1 and OR51A1P
are pseudogenes. Relative expression levels of the six OR genes in
human brain revealed wide expression levels. Specifically,
OR51V1 was expressed 25-fold more than OR51A1P, which
was expressed at the lowest level of all genes. The four functional
genes were expressed 5-fold less than OR51V1 but relatively
equally (Fig. 2B).
Discussion
The olfactory receptor repertoire represents one of the largest
human gene families [8] comprising 388 functional genes and 414
pseudogenes [9]. ORs are the largest family of G-protein coupled
Figure 1. Characterization of the 39 breakpoint of the 118 kb deletion. (A) Amplification of the 376 bp deletion breakpoint in heterozygous
and homozygous individuals with the 118 kb deletion. The normal and mutant alleles are denoted by the 482 bp and 376 bp amplicons, respectively.
(B) DNA sequence of the 376 bp breakpoint sequence. The 59 end of the breakpoint at the db-globin intergenic region is un-bolded while its 39 end is
bolded and is at the olfactory receptor cluster breakpoint. The sequences of PCR primers are underlined at both ends. (C) Physical map of the region
that separates the two breakpoints shows that it consists of 118,475 bp and encompasses 6 olfactory receptor (OR) genes. (D) Absence of PCR
amplification from the b-globin gene and OR genes OR51V1, OR52Z1, OR51A1P, OR52A1, OR52A5, OR52A4 in two individuals homozygous for the
118 kb deletion. PCR analysis of normal (N), heterozygous (Het) and homozygous (Hom) individuals shows the absence of specific amplicons in
homozygous individuals only. Amplicons from d-globin, OR52J1P and OR52E2, which are outside the deleted region are present in all individuals. The
top band in each gel represents an internal control (IC) amplicon from the cystic fibrosis gene, which is amplified in the same reaction to demonstrate
successful amplification, whenever the target amplicon is deleted.
doi:10.1371/journal.pone.0017327.g001
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receptors and their classification into genes and pseudogenes relies
on the presence in their encoded protein sequences of an
extracellular amino terminus for ligand binding, seven transmem-
brane helices for membrane potential and a carboxy intracellular
terminus for signal transduction. In this context, OR52Z1,
OR52A1, OR52A5 and OR52A4 are functional genes and their
absence in b-thalassemia individuals homozygous for the 118 kb
deletion raises the question as to whether it would result in altered
olfaction. This association would be particularly revealing as it will
provide an approach to link particular ligands to their cognate
receptors. As these studies require the recruitment of reasonably
sized cohorts of b-thalassemia patients homozygous for the 118 kb
deletion, they would most appropriately be carried out on patients
from the Philippines, Malaysia and Indonesia where the combined
population of about 300 million individuals carries the highest b-
thalassemia incidence worldwide [10]. In fact, the 118 kb deletion
occurs at about 3%, 7.8% and 46% in Indonesia, Malaysia and
the Philippines, respectively [11,12,13] and the overall b-
thalassemia carrier rate in these countries ranges from 6–10% in
Indonesia [11,14], 3.5–4.5% in Malaysia [15] and 1–2% in the
Philippines [7,13].
The association of olfactory impairment is well-documented in a
congenital disorder such as Kallmann syndrome [16] in which
olfactory receptors are lacking and in neurodegenerative disorders
such as Alzheimer’s disease, mild cognitive impairment [17] and
Parkinson’s disease [18] that are accompanied with a progressive
impairment in the sense of smell. Although none of these is
attributed directly to specific OR gene defects, the inability of
individuals to smell low levels of isovaleric acid was linked to a
nonsense mutation in the olfactory receptor OR11H7P [19].
Heterozygous OR deletions or single gene OR homozygous
deletions other than the one reported here, were noted in cell lines
[20] but not in individuals. To our knowledge, this is the first
example of a homozygous deletion that encompasses multiple
olfactory receptor genes and it is coincidental that it occurs in
homozygous b-thalassemia individuals afflicted with a transfusion-
dependent severe anemia. This finding opens the possibility that
other diseases with an underlying causative gene, which is subject to
deletions and which is located near an olfactory receptor region
could recapitulate a similar situation. For example, mutations in the
human aspartoacylase gene, which is flanked by an olfactory
receptor rich-region on chromosome 17p13.3, cause Canavan
disease. A rare 190 kb deletion spanning the aspartoacylase gene
was found in two homozygous individuals and although the deletion
extended to the adjoining OR gene region, it did not encompass any
OR gene and stopped short of OR1D2 (also called OR17-4) [21].
Whether b-thalassemia individuals homozygous for the 118 kb
deletion have altered olfaction needs to be ascertained to
Figure 2. Topology of OR proteins and gene expression. (A) Computer prediction models of the 6 OR proteins encompassed by the 118 kb
deletion. Characteristic features of functional GPCRs are shown for OR52A1, OR52A5, OR52A4, OR52Z1, including an extracellular amino-terminus, 7
TMHs, and a cytoplasmic carboxy-terminus. OR51V1 and OR51A1P have 6 TMHs and two extracellular termini. (B) Relative expression levels of
OR52A1, OR52A4, OR52A5, OR52Z1, OR51V1, OR51A1P mRNA in brain by qPCR. All amplifications were run in triplicates for each OR and normalized
to an actin internal control mRNA. Displayed data (means and standard deviations) are normalized to OR51A1P.
doi:10.1371/journal.pone.0017327.g002
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determine the impact on the overall management of their disease.
Although we have not found any evidence in the recent scientific
literature that the olfactory receptors encompassed by the 118 kb
deletion have been deorphaned, it was noted that most human
homologs of rodent ORs for n-aliphatic odorants are found at a
single locus on chromosome 11p15 [22], which is also the location
of the b-globin gene [23]. Thus, any olfactory screen for
individuals homozygous for the 118 kb deletion ought to take
into account the presence of n-aliphatic odorants in the assay. The
commercial availability of the ‘‘Sniffin’ Sticks’’ assay [24], a widely
used clinical test for olfaction, should ease the implementation of
such a screening initiative. The issue whether absence of four OR
genes among a total repertoire of 388 functional OR genes could
cause an olfactory defect may at first seem unlikely but worth
exploring. Impairment of olfactory sensitivities were found in even
single OR genes. As indicated earlier, olfactory impairment to
isovaleric acid was noted in individuals homozygous for a nonsense
mutation in the OR gene OR11H7 [19] while individuals
homozygous for two amino acid substitutions (R88W and
T133M) in OR7D4 had an altered sensitivity to androstenone
and androstadienone [25]. Thus, it is conceivable that deletion of
multiple OR genes in homozygous individuals may result in
altered olfactory abilities to specific odorants. A positive
association would have a significant impact on the biology of
olfactory receptors as only few ligands have been identified for
human ORs [19,26,27,28,29].
Brain-specific expression of the six OR genes encompassed by
the 118 kb deletion was variable whereas that of the four
functional OR genes was similar and is characteristic of G-
proteins coupled receptor gene regulation [30]. Nonetheless, the
differential expression of pseudogenes OR51V1 and OR51A1P
may be explained on the basis that expressed pseudogenes are
likely to have recently emerged [31] and thus retained their
expression levels prior to their divergence into non-functional
genes. In this vein, OR51V1 appears to have arisen more recently
than OR51A1P.
Of particular interest to b-thalassemia is OR52A1, which was
previously shown to contain a c-globin enhancer element that
confers continuous expression of the two fetal c-globin genes [4,5]
that are overexpressed in b-thalassemia and tend to alleviate the
anemia by increasing hemoglobin F production. We hypothesize
that the absence of this enhancer from b-thalassemia patients
homozygous for the 118 kb deletion may contribute to a
significant reduction of their compensatory c-globin gene
expression, leading to lower hemoglobin F levels and an
exacerbation of their anemia. In support of this hypothesis is a
study of 20 Malaysian children homozygous for this deletion, who
were described to have a severe anemia [10]. While recent
genome-wide association studies aimed at mapping modifier genes
which influence clinical severity of sickle cell anemia and Hb E/
b0-thalassemia revealed linkages to the OR region upstream of the
b-globin gene [32,33], our present studies are consistent with the
hypothesis that the OR52A1 [4,5] locus in the downstream OR
region plays an important role in influencing clinical severity in
this type of b-thalassemia.
In conclusion, we report on three main findings. First, the
occurrence of a homozygous deletion spanning four functional OR
genes and two OR pseudogenes in a subset of patients affected
with b-thalassemia. This is the first example of a homozygous
deletion of four contiguous and functional OR genes in human
individuals. Although it remains to be determined whether the
homozygous deletion of these ORs actually causes impaired
olfaction, its wide occurrence in Southeast Asia should allow such
an evaluation using commercially available standardized smell test
assays. Second, the deletion of the c-globin enhancer by the
118 kb deletion raises the suspicion that its absence may
exacerbate this b-thalassemia phenotype. Third, the size of this
deletion has been confirmed to be 118 kb, rather than 45 kb, and
should be referred to as such in the literature and in molecular
diagnostic reports.
Materials and Methods
Breakpoint amplification and genotyping of individuals
with the Filipino deletion
A PCR amplification reaction targeting the deletion breakpoint
in normal, heterozygous and homozygous mutant individuals with
the Filipino deletion was modified to detect simultaneously the
normal and mutant alleles using three PCR primers 45F: 59 TCA
GAA GCA GAG CTA CTC AG 39; 45R1- 59 GTC TAT GCA
GGT GTG TAG ACA 39 and 45R2: 59 CAT TTA GCT CCC
ACA CTC CT 39. The normal and mutant allele amplicons
consisted of 482 bp and 376 bp, respectively. Each PCR was
carried out in a 25 ml reaction consisting of a Qiagen multiplex
mix with 30, 20 and 10 pmol/ml of primers 45F, 45R1 and 45R2,
respectively. Cycling and temperature conditions consisted of an
Table 1. PCR primers used for genotyping individuals at each of the specified locus.
Region Forward primer (59 to 39) Reverse primer (59 to 39) Amplicon size (bp)
d-globin GGTTTCTGAGTCAAGACAC CAGTATTCTATGCCTCTCAT 1051
b-globin GCTGTCCAATTTCTATTAAAGG CAGCATAGCAAAACTTTAACCTC 375
OR52E2 CCATCCCTAAGATGCTTGGA AAAGCCCTCACAAACACACC 231
OR52A5 CACCATCTTTTCCCAGCAGT GGATTGCAAAGGCAACAAAT 225
OR52A4 GTTGGTGGGCTTGACTTCAT GAGGAATGGTGGGACCAGTA 247
OR52A1 AATCTGAGCGCAGTCTCCAT CACATTTGAAGCAAGCAGGA 157
OR52Z1 CATAGCAGCTGTGGTCAGGA GCCACAGTGAGGCCATAAAT 167
OR51A1P GCGCTACACAACCATTCTGA GTGTCTCCACAGGGCAATTT 185
OR51V1 CTTTCCATCCCCTTCTCCTC AATAGGACTGGGCAATGCAG 229
OR52J1P GAGTATTGGCAGGCATTGGT3 GAAGCCACAAAAAGCCCATA 196
CFTR Internal
control
GCCCGACAAATAACCAAGTGA GCTAACACATTGCTTCAGGCT 454
doi:10.1371/journal.pone.0017327.t001
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initial denaturation at 95uC for 15 min. followed by successive
annealing temperatures of 65uC, 63uC, 61uC, 59uC, 57uC, for the
first 4 cycles followed by 30 cycles at 55uC. All subsequent
denaturation (94uC) and extension (72uC) steps were for 30 sec
each. Reactions were then resolved on a 1% agarose gel and
visualized under ultraviolet light with SYBR Safe green.
DNA sequence alignment of the 39 end deletion
breakpoint
The DNA sequence of the mutant amplicon generated in the
deletion breakpoint PCR described above was determined by
standard dideoxy sequencing and aligned to the Genbank 177.0
release using the National Center for Biotechnology Information
(NCBI) Basic Local Alignment Search Tool (BLAST).
Mapping of the deletion breakpoints
PCR primers for the d-globin, b-globin and OR genes,
OR52E2, OR52A5, OR52A4, OR52A1, OR52Z1, OR51A1P,
OR51V1, OR52J1P and the CFTR internal control are shown in
Table 1. PCR products were resolved on 8% native polyacryl-
amide gels and stained with SYBR Safe green.
Expression of OR genes
Total human brain RNA was purchased from Clontech and
aliquots converted to cDNA. Real-time quantitative PCR was
carried out on a Roche LightCycler 480 using brain cDNA, a
SYBR Green I PCR mix (Roche) and the same primers listed
above for mapping the deletional breakpoint. Data analysis was
performed with the QGene Software [34] and the expression
results normalized to OR51A1P.
Transmembrane helices prediction
Membrane topology of the six ORs was predicted using a web-
based algorithm (http://www.cbs.dtu.dk/services/TMHMM/)
[35] and a stand alone Java-based application [36], which was
used to graphically display the models in Fig. 2A. The following
NCBI reference sequences were used: OR52Z1 (predicted
from NG_004304.6), OR52A1 (NP_036507.2), OR52A5 (NP_
001005160.1), OR52A4 (NP_001005222.1), OR51V1 (NP_
001004760.2) OR51A1P (predicted from NG_002199.3).
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